Pulmonary Vein Stenting for the Treatment of Acquired Severe Pulmonary Vein Stenosis after Pulmonary Vein Isolation: Clinical Implications after Long-Term Follow-Up of 4 Years

2008 ◽  
Vol 20 (3) ◽  
pp. 251-257 ◽  
Author(s):  
THOMAS NEUMANN ◽  
MALTE KUNISS ◽  
GUIDO CONRADI ◽  
JOHANNES SPERZEL ◽  
ALEXANDER BERKOWITSCH ◽  
...  
2018 ◽  
Vol 53 (3) ◽  
pp. 309-315 ◽  
Author(s):  
Elisabeth Iversen ◽  
Erik J. S. Packer ◽  
Synne M. Sandberg ◽  
Øyvind Bleie ◽  
Per Ivar Hoff ◽  
...  

2017 ◽  
Vol 13 (1) ◽  
pp. 124-130 ◽  
Author(s):  
Jason F. Goldberg ◽  
Craig L. Jensen ◽  
Rajesh Krishnamurthy ◽  
Nidhy P. Varghese ◽  
Henri Justino

2010 ◽  
Vol 26 (4) ◽  
pp. 440-448 ◽  
Author(s):  
Shingo Maeda ◽  
Yoshito Iesaka ◽  
Kiyoshi Otomo ◽  
Kikuya Uno ◽  
Yasutoshi Nagata ◽  
...  

2011 ◽  
Vol 27 (Supplement) ◽  
pp. OP07_1
Author(s):  
Yuko Nakazawa ◽  
Takashi Ashihara ◽  
Akashi Miyamoto ◽  
Tomoya Ozawa ◽  
Yoshihisa Sugimoto ◽  
...  

2019 ◽  
Vol 40 (Supplement_1) ◽  
Author(s):  
D Musat ◽  
N Milstein ◽  
R Shaw ◽  
A Bhatt ◽  
M Preminger ◽  
...  

Abstract Background Cryoballoon (CB) pulmonary vein isolation (PVI) is increasingly being used in patients (pts) with persistent atrial fibrillation (AF). However, there are limited data about the pattern of atrial fibrillation (AF) recurrence in these pts. Objective To assess, using an implantable loop recorder (ILR), the patterns of AF recurrence following CB PVI in pts with persistent atrial fibrillation. Methods We enrolled consecutive pts with persistent AF ablation undergoing their first CB ablation. Other cavotricuspid isthmus ablation when indicated, no other ablation was performed. A Reveal LINQ ILR (Medtronic) was implanted <3 months following ablation; all pts had a minimum of 1-year follow-up. The recurrence of any atrial arrhythmia was determined and adjudicated; 4 distinct AF patterns were characterized (Figure). Results We studied 64 pts (66±9 years; 50 [78%] male; CHA2DS2-VASc 2.6±1.9) with persistent AF; 52 (81%) pts were on an antiarrhythmic drug (AAD) peri-ablation. During 803±361 days of follow-up, 33 (52%) pts had their 1st AF recurrence 91–365 days post-ablation and another 17 (27%) pts had their 1st AF recurrence >365 days post-ablation. No AF was seen in 14 (31%) pts. Most pts (33 of 50, 66%) with AF recurrence presented with 1 of 3 distinct patterns of paroxysmal AF (Figure), which ranged from 22 min to 124 hours. In 2/3 of these pts, all AF recurrences lasted <24 hours. Only 17 (34%) pts recurred with persistent AF. Conclusion Following single CB PVI, most pts with persistent AF remained free of persistent AF during long-term follow-up. Most pts with recurrent AF have 1 of 3 distinct patterns with episodes commonly last <24 hours. These data suggest that CB PVI ablation may halt AF progression in pts initially presenting with persistent AF.


Sign in / Sign up

Export Citation Format

Share Document